» Articles » PMID: 29941052

Causality and Preventability Assessment of Adverse Drug Events of Antibiotics Among Inpatients Having Different Lengths of Hospital Stay: a Multicenter, Cross-sectional Study in Lahore, Pakistan

Overview
Publisher Biomed Central
Specialty Pharmacology
Date 2018 Jun 27
PMID 29941052
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A large number of hospital admissions are attributed to adverse drug reactions (ADRs) and they are the fifth leading cause of death worldwide. The present study aimed to assess the causality and preventability of adverse drug events (ADEs) of antibiotics among inpatients having different lengths of hospital stay.

Methods: A prospective, observational study was conducted in four tertiary-care public sector hospitals of Lahore, Pakistan. Study population consisted of hospitalized patients who were prescribed one or more antibiotics. Data were collected between 1st January, 2017 and 30th June, 2017 from 1249 patients. Naranjo score, modified Schumock and Thornton scale were used for causality and preventability assessments, respectively. Medication errors (MEs) were assessed by MEs tracking form. SPSS and Microsoft Excel were used for data analysis.

Results: A total of 2686 antibiotics were prescribed to 1249 patients and 486 ADEs were found. The preventability assessment revealed that most of the ADEs (78.8%) were found among patients having long length of stay (LOS) in hospital and were preventable (59.3% of the ADEs were definitely preventable while 44.7% were probably preventable) and caused by MEs including wrong drug (40.1%) and monitoring errors (25%). The errors were caused due to non-adherence of policies (38.4%) and lack of information about antibiotics (32%). Most of the non-preventable ADEs or ADRs among patients having long and short LOS in hospital were "probable" (35.5%) and "possible" (35.8%), respectively. Logistic regression analysis revealed that ADEs were significantly less among females (OR = 0.047, 95% CI = 0.018─0.121, p-value = < 0.001), patients aged 18─52 years (OR = 0.041, 95% CI = 0.013─0.130, p-value = < 0.001), patients with ARTIs (OR = 0.004, 95% CI = 0.01-0.019, p-value = < 0.001), patients prescribed with 2 antibiotics per prescription (OR = 0.455, 95% CI = 0.319─0.650, p-value = < 0.001) and patients with long LOS (OR = 14.825, 95% CI = 11.198─19.627, p-value = < 0.001).

Conclusion: Antibiotics associated definitely preventable ADEs were more commonly found in patients having long LOS in the inpatient departments because of MEs and lack of proper pharmacovigilance system. The ADRs showed a probable and possible causal association with both β-lactams and non β-lactams antibiotics.

Citing Articles

Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational follow-up study.

Sendekie A, Kassie Netere A, Tesfaye S, Dagnew E, Belachew E PLoS One. 2023; 18(2):e0282096.

PMID: 36827307 PMC: 9955665. DOI: 10.1371/journal.pone.0282096.


Individual Pharmacotherapy Management (IPM)-IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy.

Wolf U, Baust H, Neef R, Steinke T Antibiotics (Basel). 2022; 11(10).

PMID: 36290039 PMC: 9599027. DOI: 10.3390/antibiotics11101381.


Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study.

Ersulo T, Yizengaw M, Tesfaye B BMC Pharmacol Toxicol. 2022; 23(1):30.

PMID: 35581618 PMC: 9115930. DOI: 10.1186/s40360-022-00570-w.


Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital.

Khan Z, Karatas Y, Kiroglu O Front Pharmacol. 2021; 12:786182.

PMID: 34867419 PMC: 8638749. DOI: 10.3389/fphar.2021.786182.


The Burden of Preventable Adverse Drug Events on Hospital Stay and Healthcare Costs in Japanese Pediatric Inpatients: The JADE Study.

Iwasaki H, Sakuma M, Ida H, Morimoto T Clin Med Insights Pediatr. 2021; 15:1179556521995833.

PMID: 33746523 PMC: 7903823. DOI: 10.1177/1179556521995833.


References
1.
Davies E, Green C, Taylor S, Williamson P, Mottram D, Pirmohamed M . Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009; 4(2):e4439. PMC: 2635959. DOI: 10.1371/journal.pone.0004439. View

2.
Stausberg J . International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA. BMC Health Serv Res. 2014; 14:125. PMC: 3984698. DOI: 10.1186/1472-6963-14-125. View

3.
Tan T, Little P, Stokes T . Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance. BMJ. 2008; 337:a437. DOI: 10.1136/bmj.a437. View

4.
Shehab N, Patel P, Srinivasan A, Budnitz D . Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008; 47(6):735-43. DOI: 10.1086/591126. View

5.
Pretorius R, Gataric G, Swedlund S, Miller J . Reducing the risk of adverse drug events in older adults. Am Fam Physician. 2013; 87(5):331-6. View